Pharma struggles to ward off yet another drug take-back program

first_img STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What’s included? GET STARTED Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. [email protected] Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED The pharmaceutical industry is playing an intensifying game of whack-a-mole as its latest battle over a so-called drug take-back program is being fought in Washington state, which could become the third state in the nation to force drug makers to finance collections of unused or unwanted medicines.The Washington bill, which was first introduced a year ago, is now gaining momentum in the state House of Representatives, where a vote may occur this week, according to legislators and lobbyists. And the lawmaker who sponsored the bill believes the state Senate will be amenable to the legislation, as well. About the Author Reprints What is it? Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry.center_img Pharma struggles to ward off yet another drug take-back program @Pharmalot Pharmalot Ed Silverman Log In | Learn More Keith Srakocic/AP By Ed Silverman Jan. 30, 2018 Reprints Tags opioidspharmaceuticalsSTAT+stateslast_img

Posts Tagged with… , , , , , , , , , , ,

Write a Comment

Your email address will not be published. Required fields are marked *